Background and Format: globalcapital.com is the website of the weekly magazine GlobalCapital that provides information on the global capital markets spanning Asia, the Middle East, Europe, Africa and the Americas. Audience and Readership: Aimed at capital markets professionals Monthly Unique Users: The publisher does not disclose this information. Ad rates: Information on ad rates can be found here.

Background and Format: The Loans department covers all stories regarding loans. Previously titled EuroWeek, GlobalCapital is a weekly magazine that provides information on the global capital markets spanning Asia, the Middle East, Europe, Africa and the Americas. Since relaunching as GlobalCapital in February 2014, the title has incorporated AsiaMoney, Derivatives Week and Total Securitization. It is published by Euromoney Institutional Investor plc. Audience and Readership: Aimed at capital markets professionals Deadline: Wednesday / Thursday Time of Publication: Friday. Frequency: Weekly, plus daily emerging markets email bulletins. Circulation: Source: Publisher

Background and Format: Medium Term Notes and Commercial Paper.

GlobalCapital - New York, NY Bureau covers News

Background and Format: The Cover is an online daily news service dedicated to the covered bond market, published by GlobalCapital. It delivers live breaking news on new covered bond issues as they are launched, as well as essential information on the secondary markets, priced deals data and covered bond regulation and the people that matter in the covered bond markets. The Cover also generates league tables on the market. It is a subscriber service. 

Background and Format: Published by Euromoney Institutional Investor PLC, GlobalCapital Derivatives forms one part of the GlobalCapital online resource. Previously a weekly magazine titled Derivatives Intelligence, GlobalCapital Derivatives now produces a daily global e-newsletter covering the derivatives market. This title provides news, information, proprietary databases and informed perspective pieces on derivatives worldwide. It also addresses regulatory challenges, and speaks to banks and issuers making deals in Europe, the Americas, the Far East and across emerging markets. Audience and Readership: Targets derivatives investors, including institutional investors and hedge funds, both long-term and new. Deadline: Ongoing Frequency: The newsletter is emailed daily to subscribers. Circulation: They do not disclose a figure for number of subscribers. Ad Rates: For advertising information and contact details, please click here. Other Information: There is no generic editorial email address; enquiries should be sent directly to the most relevant individual. Can be found on GooglePlus here The RSS feed can be viewed here Alerts: Gorkana Alert: Monday 3 March 2014 EuroWeek is relaunching today as GlobalCapital. The new title also incorporates AsiaMoney, Derivatives Week and Total Securitization and is the launch platform for GlobalRMB, a news and data service on the offshore renminbi market. GlobalCapital will also continue to take the form of a weekly print title covering global capital markets. The website for GlobalCapital can now be found at www.globalcapital.com. Managing Editor Toby Fildes can be reached on +44 (0)20 7779 7327 and toby.fildes@globalcapital.com

Background and Format: GlobalCustody.net is a provider of information on custody and fund administration resources such as service providers and service offerings, rankings and ratings, and news and events. Audience and Readership: The service is aimed at fund managers, institutional investors, broker-dealers and custodians. Deadline: Ongoing Frequency: Online Monthly Unique Users: The MUU figure is not disclosed. Distribution: Online Ad rates: For ad rates contact via the website contact facility box. The media pack can be found here. <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Med

Global Data covers Databases & Big Data, Financial Services, Innovation & Invention, News, Technology

BioPharm Insight (BPI) is a team of investigative journalists, and owned by the Financial Times Group. The editorial team operates out of New York, London and Shanghai and covers a pipeline of events by aggregating and reviewing data about thousands of upcoming pivotal drug development events, plus equity research, Wall Street data, industry news releases, and historical coverage. The news operation is only one part of an online business intelligence system that also includes market analytics, and a database of industry contacts. The team covers everything in healthcare, from drug development and research, partnerships/licensing, M&A, regulatory, reimbursement, medical devices, healthcare services, CROs, CMOs, among others. The majority of their journalists have graduate degrees in the sciences, or years of scientific reporting. They are versed in understanding clinical trials data, as well as deciphering statistics. This enables BPI to uncover news and build relationship with doctors, scientists, company executives and other opinion leaders. BioPharm Insight is published by Infinata, part of the Financial Times Group of companies and a division of Pearson plc. BioPharm Insight does not provide user/circulation figures.   New York DMA